Approaches to the Treatment of Hypercholesteremia
Authors: STANLEY S. BERGEN
Journal: Annals of Internal Medicine (1963)

Review1 February 1963Approaches to the Treatment of HypercholesteremiaSTANLEY S. BERGEN JR., M.D., THEODORE B. VAN ITALLIE, M.D., F.A.C.P.STANLEY S. BERGEN JR., M.D.Search for more papers by this author, THEODORE B. VAN ITALLIE, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-58-2-355 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe statistical association of an elevated level of cholesterol in the serum with an increased risk of coronary atherosclerosis seems well established. Many physicians treat patients who have hypercholesteremia with agents or diets believed effective in lowering the cholesterol level; however, the evidence that such measures can retard or arrest coronary artery dissease remains circumstantial (1-3).Nevertheless, a number of agents and regimens are now available that purport to be effective in lowering cholesterol and they are receiving wide attention. It is the purpose of this paper to summarize briefly recent information about cholesterol metabolism and the various procedures that...References1. AMSTERDAM B: Fats, cholesterol, lipoproteins and atherosclerosis-facts, fallacies, fancies, and formulas for therapy. New York J. Med. 58: 2199, 1958. MedlineGoogle Scholar2. FELCHSINISTERRAVAN ITALLIESTARE WCLTBFJ: Vitamins and other nutrients in cardiovascular disease. Vitamins Hormones (NY) 16: 128, 1958. Google Scholar3. MANN GV: Diet and coronary heart disease. Arch. Intern. Med. (Chicago) 104: 921, 1959. CrossrefMedlineGoogle Scholar4. Cook RP Cholesterol: Chemistry, Biochemistry, and Pathology, ed. by , Academic Press, Inc., New York, 1958, p. 181. Google Scholar5. PAGESTARECORCORANPOLLACKWILKINSON IHFJACHCF: Atherosclerosis and the fat content of the diet. Circulation 16: 163, 1957. CrossrefMedlineGoogle Scholar6. BEVERIDGECONNELLHAUSTMAYER JMWFHLGA: Dietary cholesterol and plasma cholesterol levels in man. Canad. J. Biochem. 37: 575, 1959. CrossrefMedlineGoogle Scholar7. CONNERHODGESBLEILER WERERE: Effects of dietary cholesterol upon serum lipids in man. J. Lab. Clin. Med. 57: 331, 1961. MedlineGoogle Scholar8. GLOVERMORTON JRA: The absorption and metabolism of sterols. Brit. Med. Bull. 14: 226, 1958. CrossrefMedlineGoogle Scholar9. FRAZER AC: Fat absorption and its disorders. Brit. Med. Bull. 14: 212, 1958. CrossrefMedlineGoogle Scholar10. ROSENFELDHELLMAN RSL: The relation of plasma and biliary cholesterol to bile acid synthesis in man. J. Clin. Invest. 38: 1334, 1959. CrossrefMedlineGoogle Scholar11. SIPERSTEINJAYKOCHAIKOFFDAUBEN MDMEILWG: Nature of the metabolic products of C14 cholesterol excreted in bile and feces. Proc. Soc. Exp. Biol. Med. 81: 720, 1952. CrossrefMedlineGoogle Scholar12. SIPERSTEINGUEST MDMJ: Studies on the site of the feedback control of cholesterol synthesis. J. Clin. Invest. 39: 642, 1960. CrossrefMedlineGoogle Scholar13. BEHERBAKER WTGD: Effect of dietary bile acids on in vivo cholesterol metabolism in the rat. Proc. Soc. Exp. Biol. Med. 98: 892, 1958. CrossrefMedlineGoogle Scholar14. BEHERBAKERANTHONY WTGDWL: Effect of dietary cholic acid on in vivo cholesterol metabolism. Proc. Soc. Exp. Biol. Med., 100: 3, 1959. CrossrefMedlineGoogle Scholar15. BEHERANTHONYBAKER WTWLGD: Influence of bile acids on cholesterol metabolism in the mouse. Proc. Soc. Exp. Biol. Med. 102: 317, 1959. CrossrefMedlineGoogle Scholar16. WHITEHOUSESTAPLE MWE: Regulation of cholesterol oxidation by liver in vitro. Proc. Soc. Exp. Biol. Med. 101: 439, 1959. CrossrefMedlineGoogle Scholar17. FRENCHMORRISROBINSON JEBDS: Removal of lipids from the bloodstream. Brit. Med. Bull. 14: 234, 1958. CrossrefMedlineGoogle Scholar18. BERGSTROMLINDSTREDTSAMUELSONCOREYGREGORIOU SSBEJGA: The sterochemistry of 7α-hydroxylation in the biosynthesis of cholic acid from cholesterol. J. Amer. Chem. Soc. 80: 2337, 1958. CrossrefGoogle Scholar19. SMITHTREADWELL ALCR: Effect of bile acid and other factors on cholesterol uptake by inverted intestinal sacs. Amer. J. Physiol. 195: 773, 1958. CrossrefMedlineGoogle Scholar20. CURRANAZARNOFF GLDL: Inhibition of cholesterol biosynthesis in man. Arch. Intern. Med. (Chicago) 101: 685, 1958. CrossrefGoogle Scholar21. WRIGHTLOEB LDM: Effect of inhibitors of oxidative phosphorylation on biosynthesis of cholesterol and precursors by liver homogenates. Proc. Soc. Exp. Biol. Med. 103: 183, 1960. CrossrefMedlineGoogle Scholar22. CURRANAZARNOFFBOLINGER GLDLRE: Effect of cholesterol synthesis inhibition in normocholesteremic young men. J. Clin. Invest. 38: 1251, 1959. CrossrefMedlineGoogle Scholar23. VITALEHELLERSTEINHEGSTEADNAKAMURAFARBMAN JJEEDMMP: Studies on the interrelationships between magnesium and calcium in atherogenesis and renal lesions. Amer. J. Clin. Nutr. 7: 13, 1959. CrossrefMedlineGoogle Scholar24. NAKAMURAVITALEHELLERSTEINHEGSTEAD MJJEEDM: Dietary magnesium and thyroxine in the progression and regression of vascular sudanophilia. Fed. Proc. 17: 486, 1958. Google Scholar25. HAYWOODSELVESTER JR: Effects of oral magnesium and potassium on serum lipids. Clin. Res. 10: 87, 1962. Google Scholar26. BLOHMKARIYALAUGHLINPAPOLI TRTMEFP: Reduction of blood and tissue cholesterol by MER-29, a cholesterol synthesis inhibitor. Fed. Proc. 18: 369, 1959. Google Scholar27. GOULDLILLYMITCHELL RGEHVE: Effects of MER-29 on tissue and plasma cholesterol concentrations and on hepatic cholesterol synthesis from mevalonic acid. Circulation 20: 965, 1959 (abstract). Google Scholar28. MOBBERLEYFRANTZ MLID: Observations concerning the site of inhibition of cholesterol synthesis by MER-29. Circulation 20: 965, 1959 (abstract). Google Scholar29. AVIGANSTEINBERGTHOMPSONMOSETTIG JDMJE: Mechanism of action of MER-29, an inhibitor of cholesterol biosynthesis. Biochem. Biophys. Res. Commun. 2: 63, 1960. CrossrefMedlineGoogle Scholar30. BLOHMKARIYALAUGHLIN TRTMW: Effects of MER-29, a cholesterol synthesis inhibitor, on mammalian tissue lipides. Arch. Biochem. 85: 250, 1959. CrossrefMedlineGoogle Scholar31. HOLLANDERCHOBANIAN WA: The effects of an inhibitor of cholesterol biosynthesis triparanol (MER-29) in subjects with and without coronary artery disease. Boston Med. Quart. 10: 37, 1959. MedlineGoogle Scholar32. OAKSLISANMOYER WPJM: Inhibition of cholesterol synthesis with the use of MER-29. Arch. Intern. Med. (Chicago) 104: 527, 1959. CrossrefMedlineGoogle Scholar33. STEINBERGAVIGANFEIGELSON DJEB: Effect of triparanol (MER-29) on cholesterol biosynthesis and on blood sterol levels in man. J. Clin. Invest. 40: 884, 1961. CrossrefMedlineGoogle Scholar34. KOUNTZ WB: Clinical observations on the effects of MER-29. Progr. Cardiov. Dis. 2: 541, 1960. CrossrefMedlineGoogle Scholar35. CARVERFREEMANSMITH MJJGJA: Evaluation of a cholesterol-synthesis inhibitor (triparanol). Ann. Intern. Med. 53: 462, 1960. LinkGoogle Scholar36. MELBYST. CYRDALE JCMSL: Reduction of adrenal-steroid production by an inhibitor of cholesterol biosynthesis. New Engl. J. Med. 264: 583, 1961. CrossrefMedlineGoogle Scholar37. KING WM: The toxicology of MER-29. Progr. Cardiov. Dis. 2: 539, 1960. CrossrefGoogle Scholar38. HUFFGILFILLAN JWJL: Benzmalecene: inhibition of cholesterol biosynthesis and hypocholesteremic effect in rats. Proc. Soc. Exp. Biol. Med. 103: 41, 1960. CrossrefMedlineGoogle Scholar39. BERGENVAN ITALLIESEBRELL SSTBWH: Hypocholesteremic effect in man of benzmalecene: an inhibitor of cholesterol biosynthesis. Proc. Soc. Exp. Biol. Med. 103: 39, 1960. CrossrefMedlineGoogle Scholar40. PAGESCHNECKLOTH IHRE: Hypocholesteremic effect of benzmalecene. Circulation 20: 1075, 1959. CrossrefMedlineGoogle Scholar41. SACHSDANIELSONSPERBER BAER: Hypocholesteremic effects of N (1-methyl 2-3-di-p-chlorophenyl-propyl) maleamic acid in hyperlipemic and normolipemic man. Circulation 20: 762, 1959. Google Scholar42. FURMANHOWARDNORCIAROBINSON RHRPLNCW: Effect of N-(1-methyl-2-3-di-p-chlorophenyl-propyl) maleamic acid (benzmalecene) on serum lipids and lipo-proteins. Proc. Soc. Exp. Biol. Med. 103: 302, 1960. CrossrefMedlineGoogle Scholar43. PARSONSFLINN WBJH: Reduction in elevated blood cholesterol levels by large doses of nicotinic acid. JAMA 165: 234, 1957. CrossrefMedlineGoogle Scholar44. PARSONSFLINN WBJH: Reduction of serum cholesterol levels and beta lipo-protein cholesterol levels by nicotinic acid. Arch. Intern. Med. (Chicago) 103: 783, 1959. CrossrefGoogle Scholar45. PARSONS WB: Treatment of hypercholesteremia by nicotinic acid: progress report with review of studies regarding mechanism of action. Arch. Intern. Med. (Chicago) 107: 639, 1961. CrossrefMedlineGoogle Scholar46. BERGEACHORCHRISTENSENPOWERBARKER KGRWNAMHNW: Hypercholesteremia and nicotinic acid: long term study. Circulation 20: 671, 1959. Google Scholar47. RIVIN AU: Jaundice occurring during nicotinic acid therapy for hypercholesteremia. JAMA 170: 2088, 1959. CrossrefMedlineGoogle Scholar48. DUNCANBEST CHMM: Lack of nicotinic acid effect on cholesterol metabolism of the rat. J. Lipid Res. 1: 159, 1960. CrossrefGoogle Scholar49. KRITCHEVSKYWHITEHOUSESTAPLE DMWE: Oxidation of cholesterol-26-C14 by rat liver mitochondria: effect of nicotinic acid. J. Lipid Res. 1: 154, 1960. CrossrefGoogle Scholar50. GAMBLEWRIGHT WLD: Effect of nicotinic acid and related compounds on incorporation of mevalonic acid into cholesterol. Proc. Soc. Exp. Biol. Med. 107: 160, 1961. CrossrefMedlineGoogle Scholar51. FAILEYBROWNHODES RBEME: Effect of nicotinic acid on conjugation pattern of bile acids in man. Circulation 20: 984, 1959. Google Scholar52. GOLDSMITH G: Mechanisms by which certain pharmacologic agents lower serum cholesterol. Fed. Proc. 21: (supp. 11) 81, 1962. MedlineGoogle Scholar53. GOLDSMITHHAMILTONMILLER GAJGON: Lowering of serum lipid concentrations. Arch. Intern. Med. (Chicago) 105: 512, 1960. CrossrefMedlineGoogle Scholar54. SCHADESALTMAN HP: Influence of nicotinic acid on hepatic cholesterol synthesis in rabbits. Proc. Soc. Exp. Biol. Med. 102: 265, 1959. CrossrefMedlineGoogle Scholar55. GAYLOR JL: Hypocholesteremic action of nicotinic acid. New York J. Med. 61: 1739, 1961. MedlineGoogle Scholar56. PERRY WF: Effect of nicotinic acid and nicotinamide on incorporation of acetate into cholesterol, fatty acids and carbon dioxide by rat liver slices. Metabolism 9: 686, 1960. MedlineGoogle Scholar57. HARDYGAYLORBAUMANN RWJLCA: Biosynthesis of sterols and fatty acids as affected by nicotinic acid and related compounds. J. Nutr. 71: 159, 1960. CrossrefMedlineGoogle Scholar58. STAREVAN ITALLIEMCCANNPORTMAN FJTBMBOW: Nutritional studies relating to serum lipids and atherosclerosis. JAMA 164: 1920, 1957. CrossrefMedlineGoogle Scholar59. HUDSONDILLERPFEIFFERDAVIS JLERRRWW: Formation of mixed crystals of cholesterol and sitosterols in vitro and rabbit intestine. Proc. Soc. Exp. Biol. Med. 102: 461, 1959. CrossrefMedlineGoogle Scholar60. DUNHAMFORTNERMOORECULPRICE LWRERDHWCN: Comparative lymphatic absorption of B sitosterol and cholesterol by the rat. Arch. Biochem. 82: 50, 1959. CrossrefMedlineGoogle Scholar61. BESTDUNCAN MMCH: Modification of abnormal serum lipid patterns in atherosclerosis by administration of sitosterol. Ann. Intern. Med. 45: 614, 1956. LinkGoogle Scholar62. WILKINSONJACKSONBOZIANBENJAMINLEVERECRAFTDAVIDSON CFRSRCMRAHGNV: Symposium on sitosterol. II. Clinical experience with sitosterols. Trans. N. Y. Acad. Sci. 18: 119, 1955. CrossrefMedlineGoogle Scholar63. CURRANCOSTELLO GLRL: Effect of dehydrocholesterol and soybean sterols on cholesterol metabolism in rabbit and rat. Proc. Soc. Exp. Biol. Med. 91: 52, 1956. CrossrefMedlineGoogle Scholar64. TENNENTSIEGELZANETTIKURONOTTWOLF DMHMEGWWHFJ: Reduction of plasma cholesterol in animals with bile acid sequestrants. Circulation 20: 969, 1959 (abstract). Google Scholar65. BERGENVAN ITALLIETENNENTSEBRELL SSTBDMWH: Effect of an anion exchange resin on serum cholesterol in man. Proc. Soc. Exp. Biol. Med. 102: 676, 1959. CrossrefMedlineGoogle Scholar66. HASHIMBERGENVAN ITALLIE SASSTB: Steatorrhea induced in man by means of bile acid sequestrant. Proc. Soc. Exp. Biol. Med. 106: 173, 1961. CrossrefMedlineGoogle Scholar67. KOWALSKI K: Serum and liver lipids in rats treated with neomycin. Proc. Soc. Exp. Biol. Med. 102: 448, 1959. CrossrefGoogle Scholar68. SAMUELSTEINER PA: Effect of neomycin on serum cholesterol level in man. Proc. Soc. Exp. Biol. Med. 100: 193, 1959. CrossrefMedlineGoogle Scholar69. SAMUEL P: Effect of neomycin, para-amino-salicylic acid and other antibacterial drugs on the serum cholesterol level of man. Circulation 20: 979, 1959. Google Scholar70. BERGSTROM S: Metabolism of bile acids. Fed. Proc. 20: (supp. 7) 121, 1961. Google Scholar71. KINSELL LW: Effect of high-fat diets on serum lipids: animal vs. vegetable fats. J. Amer. Diet. Ass. 30: 685, 1954. CrossrefMedlineGoogle Scholar72. BRONTE-STEWARTANTONISEALESBROCK BALJF: Effects of feeding different fats on serum-cholesterol level. Lancet 1: 521, 1956. CrossrefGoogle Scholar73. AHRENSHIRSCHINSULLTSAITASBLOMSTRENDPETERSON EHJWTTRML: Dietary control of serum lipids in relation to atherosclerosis. JAMA 164: 1905, 1957. CrossrefMedlineGoogle Scholar74. JOLLIFFE N: Fats, cholesterol and coronary heart disease. New York J. Med. 57: 2684, 1957. MedlineGoogle Scholar75. SHOENHEIMER R: Uher eine Storung der Cholesterin-Ausscheidung (ein Beitrag zur Kenntnis der Hypercholesterenamien). Z. Klin. Med. 123: 749, 1933. Google Scholar76. AHRENSDOLEBLANKENHORN EHVPDH: The use of orally fed lipid formulas in metabolic studies. Amer. J. Clin. Nutr. 2: 336, 1954. CrossrefMedlineGoogle Scholar77. SINCLAIR HM: Deficiency of essential fatty acids and atherosclerosis. Lancet 1: 381, 1956. Google Scholar78. HOLMAN RT: Essential fatty acids in nutrition and metabolism. Arch. Intern. Med. (Chicago) 105: 33, 1960. CrossrefMedlineGoogle Scholar79. AHRENSINSULL EHW: The effect on human serum-lipids of a dietary fat, highly unsaturated, but poor in essential fatty acids. Lancet 1: 115, 1959. CrossrefMedlineGoogle Scholar80. GORDONLEWISEALESBROCK HBLJF: Dietary fat and cholesterol synthesis, faecal elimination of bile acids and other lipids. Lancet 2: 1299, 1957. CrossrefGoogle Scholar81. BYERSFRIEDMAN SOMF: Bile acid metabolism, dietary fats and plasma cholesterol levels. Proc. Soc. Exp. Biol. Med. 98: 523, 1958. CrossrefMedlineGoogle Scholar82. LEWIS B: Effect of certain dietary oils on bile-acid secretion and serum-cholesterol. Lancet 1: 1090, 1958. CrossrefMedlineGoogle Scholar83. SIPERSTEINWILSON MDJD: Effect of saturated and unsaturated fats on fecal excretion of end products of cholesterol-4-C14 metabolism in the rat. Amer. J. Physiol. 196: 596, 1959. CrossrefMedlineGoogle Scholar84. WEINRABGERMANROSENBERG HLEB: A study of myocardial infarction in women. Ann. Intern. Med. 46: 285, 1957. LinkGoogle Scholar85. COCHRANPOTE BWW: The effects of 2 synthetic estrogens on hypercholesteremia accompanying diabetes mellitus. Clin. Res. 7: 64, 1959. Google Scholar86. ROBINSONCOHENHIGANO RWWDN: Estrogen replacement therapy in women with coronary atherosclerosis. Ann. Intern. Med. 48: 95, 1958. LinkGoogle Scholar87. BARR DP: Influence of sex and sex hormones upon the development of atherosclerosis and upon the lipoprotein of plasma. J. Chron. Dis. 1: 63, 1955. CrossrefMedlineGoogle Scholar88. BOYD GS: Effect of linoleate and estrogen on cholesterol metabolism. Fed. Proc. 21: (supp. 11) 86, 1962. MedlineGoogle Scholar89. ROBINSONHIGANOCOHEN RWNWD: Effects of estradiol-17a in males with coronary heart disease. Circulation 20: 990, 1959. Google Scholar90. HOODCRAMER BK: Effects on serum lipo-protein cholesterol of estrogen in combination with Δ 4-androstenedione, testosterone and methyl testosterone. Acta Med. Scand. 165: 459, 1959. CrossrefMedlineGoogle Scholar91. BOYD GS: The thyroid, iodothyronines and atherosclerosis. J. Atheroscler. Res. 1: 26, 1961. CrossrefGoogle Scholar92. HAMOLSKYFREEDBERG MWAS: The thyroid gland. New Engl. J. Med. 262: 70, 129, 1960. CrossrefMedlineGoogle Scholar93. CUTHBERTSONELCOHTEIRELANDMILLSSHEARLEY WJPVDMDCP: Effect of compounds related to thyroxin on serum and liver cholesterol and on atherosclerosis and heart weight in rats and mice. J. Endocr. 21: 45, 1960. CrossrefMedlineGoogle Scholar94. BESTDUNCAN MMCH: Effects of d-thyroxin and d-triiodothyronine on cholesterol metabolism. Clin. Res. 8: 81, 1960. Google Scholar95. BESTDUNCAN MMCH: Thyroid hormones and cholesterol metabolism: effects of side-chain substitutions. Circulation 20: 981, 1959 (abstract). Google Scholar96. STARR P: Depression of the serum cholesterol in myxedematous patients by an oral dosage of sodium dextrothyroxine which has no effect on the basal metabolic rate or electrocardiogram. J. Clin. Endocr. 20: 116, 1960. CrossrefGoogle Scholar97. SCHAEFERADLERSBERG LED: Effect of triiodothyropropionic acid on circulating lipids of euthyroid adults. Clin. Res. 7: 23, 1959. Google Scholar98. JONES RJ: Serum cholesterol reduction with d-thyroxine. Circulation 20: 979, 1959. Google Scholar99. BAUERMCGAVACKSWELL HGTHL: Depression of the serum cholesterol level by triiodothyropropionic acid. J. Clin. Endocr. 19: 490, 1959. CrossrefGoogle Scholar100. ENGELBERG H: Short term studies of effect of heparin upon cholesterol excretion in man. Proc. Soc. Exp. Biol. Med. 102: 365, 1959. CrossrefMedlineGoogle Scholar101. HERBERTBEAMISHPERRY FAREWF: Serum cholesterol levels in atherosclerotic patients treated with oral anticoagulants. J. Lab. Clin. Med. 53: 442, 1959. MedlineGoogle Scholar102. MONKHOUSEMCCLAINBAKER FCFDG: Action of protamine on production and activity of heparin induced clearing factor. Proc. Soc. Exp. Biol. Med. 102: 50, 1950. CrossrefGoogle Scholar103. CHERKESGORDON ARS: The liberation of lipoprotein lipase by heparin from adipose tissue incubated in vitro. J. Lipid Res. 1: 97, 1959. CrossrefGoogle Scholar104. MANGIERICAIN CNRA: Demonstration of lipemia-clearing activity after sublingual administration of heparin potassium in the rabbit. Angiology 12: 136, 1961. CrossrefMedlineGoogle Scholar105. MICHAJLIKBRAGDON AJH: Effects of intravenous heparin on oxidation of fat. J. Lipid Res. 1: 164, 1960. CrossrefGoogle Scholar106. SHERBERMARCUS DAM: In vitro effects of heparin on human blood lipoprotein. Circulation 20: 977, 1959. Google Scholar107. ENGELBERG H: Effect of heparin on serum cholesterol and triglycerides, fecal bile acids and digitonin-precipitable sterols. Circulation 20: 976, 1959. Google Scholar108. FULLER HL: Sublingual heparin in hyperlipemia. Angiology 9: 311, 1958. CrossrefMedlineGoogle Scholar109. HIRSHLEIFERNAYAK IR: Lipemia clearing effect of buccally administered heparin potassium (clarin). Amer. J. Med. Sci. 241: 645, 1961. CrossrefMedlineGoogle Scholar110. BIANCANI G: The effect of sublingual heparin on lipoprotein distribution in atherosclerosis. Angiology 12: 119, 1961. CrossrefGoogle Scholar111. KINLEYKRAUSE LJRF: Influence of vitamin A on cholesterol blood levels. Proc. Soc. Exp. Biol. Med. 102: 353, 1959. CrossrefMedlineGoogle Scholar112. SULKINSULKIN NMDF: Intimal lesions in arteries of vitamin E deficient rats. Proc. Soc. Exp. Biol. Med. 103: 111, 1960. CrossrefMedlineGoogle Scholar113. AFTERGOODDEUELALFIN-SLATER LHJRB: Comparative effects of cottonseed oil and lard on cholesterol levels in tissues of rats. J. Nutr. 62: 129, 1957. CrossrefMedlineGoogle Scholar114. RINEHARTGREENBERG JFLD: Arteriosclerotic lesions in pyridoxine-deficient monkeys. Amer. J. Path. 25: 481, 1949. MedlineGoogle Scholar115. WAYNEWILLFRIEDMANBECKERVILTER LJJBILSRW: Vitamin B6 in internal medicine. Arch. Intern. Med. 101: 143, 1958. CrossrefGoogle Scholar116. KIRSCHMANCONIGLIO JCJG: The role of pyridoxine in the metabolism of polyunsaturated fatty acids in rats. J. Biol. Chem. 236: 2200, 1961. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New York, New YorkFrom the St. Luke's Convalescent Hospital, Greenwich, Connecticut, and the Medical Service, St. Luke's Hospital, New York, New York.The studies done at St. Luke's Hospital have been supported in part by a series of grants from the National Institutes of Health and the Nutrition Foundation.Requests for reprints should be addressed to Theodore B. Van Itallie, M.D., St. Luke's Hospital, Morningside Heights, Amsterdam Avenue and 113th Street, New York, New York. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byIn memoriam: The life and times of Theodore B. Van Itallie (1919–2019)Medikament�se Behandlung prim�rer Hyperlipoprotein�mienHypolipaemic drugs and coronary heart diseaseAn Effective Treatment of Hypercholesterolaemia Using a Combination of Secholex® and ClofibrateThe Combined Use of Clofibrate and Anion Exchange in the Treatment of HypercholesterolemiaRadiographic determination of Achilles tendon xanthoma size6 The Literature of Medicinal ChemistryHYPOCHOLESTEROLÆMIC EFFECT OF AN ANABOLIC STEROID, METHALONETherapy of hypercholesterolemiaUse of an anion exchange resin in treatment of two siblings with familial hypercholesterolemia 1 February 1963Volume 58, Issue 2Page: 355-366KeywordsCholesterolCoronary arteriesDietHypercholesterolemiaMedical servicesNutritionStable coronary artery disease Issue Published: 1 February 1963 PDF downloadLoading ...